We are live on ! Find out more
ZYME icon

Zymeworks

139 hedge funds and large institutions have $396M invested in Zymeworks in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 49 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

26% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 39

16% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 19

1% more funds holding

Funds holding: 137139 (+2)

6.94% less ownership

Funds ownership: 98.83%91.89% (-6.9%)

12% less call options, than puts

Call options by funds: $607K | Put options by funds: $688K

28% less capital invested

Capital invested by funds: $548M → $396M (-$152M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
139
Holders Change
+2
Holders Change %
+1.46%
% of All Funds
2.21%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
22
Increased
49
Reduced
39
Closed
19
Calls
$607K
Puts
$688K
Net Calls
-$81K
Net Calls Change
+$1.02M
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
EcoR1 Capital
California
$85.2M
BI
2
BVF Inc
California
$37.2M
RG
3
Redmile Group
California
$35.9M
Morgan Stanley
4
Morgan Stanley
New York
$28.4M -$7.39M -1,001,080 -18%
BlackRock
5
BlackRock
New York
$22.9M +$563K +76,297 +2%
RCMNY
6
Rubric Capital Management (New York)
New York
$16.8M +$2.17M +293,817 +12%
CS
7
Credit Suisse
Switzerland
$15.9M -$148K -20,064 -0.8%
Vanguard Group
8
Vanguard Group
Pennsylvania
$15.1M +$972K +131,604 +6%
FCM
9
Farallon Capital Management
California
$12.7M
BNP Paribas Asset Management
10
BNP Paribas Asset Management
France
$9.88M -$4.55M -616,349 -28%
SB
11
Samsara BioCapital
California
$9.25M
PA
12
Perceptive Advisors
New York
$9.17M -$7.16M -970,109 -40%
TCM
13
Tang Capital Management
California
$6.97M
State Street
14
State Street
Massachusetts
$5.94M +$227K +30,777 +3%
Acadian Asset Management
15
Acadian Asset Management
Massachusetts
$5.23M +$5.38M +727,934 +742%
AQR Capital Management
16
AQR Capital Management
Connecticut
$5.07M +$2.44M +330,213 +70%
GIM
17
Granahan Investment Management
Massachusetts
$4.57M +$584K +79,039 +12%
BCM
18
Bridgeway Capital Management
Texas
$4.16M +$667K +90,382 +16%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$3.8M +$277K +37,536 +7%
JAM
20
Jupiter Asset Management
United Kingdom
$3.01M +$3.16M +427,860 +913%
Arrowstreet Capital
21
Arrowstreet Capital
Massachusetts
$2.99M -$519K -70,225 -13%
Northern Trust
22
Northern Trust
Illinois
$2.66M -$8.57K -1,161 -0.3%
MAM
23
Monaco Asset Management
Monaco
$2.64M +$49.9K +6,755 +2%
PIM
24
Platinum Investment Management
Australia
$2.6M
SAM
25
Silvercrest Asset Management
New York
$2.38M -$7.02K -950 -0.3%

ZYME Hedge Fund Activity: Q3 2023 in Review

139 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q3 2023, worth a combined $396M — down 28% from $548M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ZYME positions and 19 closed out — a net gain of 3 holders — while 49 added to existing stakes and 39 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $5.38M. The largest seller was Morgan Stanley, cutting an estimated $7.39M.

  • 139 institutional investors held Zymeworks (ZYME) as of Q3 2023, up from 137 in Q2 2023.
  • Funds reported $396M of Zymeworks stock for Q3 2023, down 28% quarter-over-quarter.
  • 22 funds opened new Zymeworks positions in Q3 2023 and 19 closed out, a net change of +3 holders.
  • The largest Zymeworks buyer in Q3 2023 was Acadian Asset Management, an estimated $5.38M added.
  • The largest Zymeworks seller in Q3 2023 was Morgan Stanley, an estimated $7.39M sold.

Based on aggregated 13F filings for Q3 2023.